 | • レポートコード：MRC23Q36289 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の家禽ワクチン市場について調査・分析し、世界の家禽ワクチン市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（生、弱体化、死）、用途別セグメント分析（NDV、マレック病、IBD、感染性気管支炎、インフルエンザ、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Merck、Boehringer Ingelheim、Ceva、Zoetis、Vaxxinova®、Elanco、QYH Biotech Co., Ltd、Pulike、Phibro Animal Health Corporation、JinYu Biotechnology、Harbin Pharmaceutical Group、MEVAC、Venky's、Japfa Comfeed Indonesia、Nisseiken、Hile、Hester Biosciencesなどが含まれています。世界の家禽ワクチン市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、家禽ワクチン市場規模を推定する際に考慮しました。本レポートは、家禽ワクチンの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、家禽ワクチンに関するビジネス上の意思決定に役立てることを目的としています。 ・家禽ワクチン市場の概要 - 家禽ワクチンのタイプ別セグメント - 世界の家禽ワクチン市場規模：タイプ別分析（生、弱体化、死） - 家禽ワクチンの用途別セグメント - 世界の家禽ワクチン市場規模：用途別分析（NDV、マレック病、IBD、感染性気管支炎、インフルエンザ、その他） - 世界の家禽ワクチン市場規模予測（2018年-2029年） ・家禽ワクチン市場の成長トレンド - 家禽ワクチンの地域別市場規模（2018年-2029年） - 家禽ワクチン市場ダイナミクス - 家禽ワクチンの業界動向 - 家禽ワクチン市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：生、弱体化、死 - 世界の家禽ワクチンのタイプ別市場規模（2018年-2023年） - 世界の家禽ワクチンのタイプ別市場規模（2024年-2029年） ・用途別セグメント：NDV、マレック病、IBD、感染性気管支炎、インフルエンザ、その他 - 世界の家禽ワクチンの用途別市場規模（2018年-2023年） - 世界の家禽ワクチンの用途別市場規模（2024年-2029年） ・家禽ワクチンの地域別市場規模 - 北米の家禽ワクチン市場規模（2018年-2029年） - アメリカの家禽ワクチン市場規模（2018年-2029年） - ヨーロッパの家禽ワクチン市場規模（2018年-2029年） - アジア太平洋の家禽ワクチン市場規模（2018年-2029年） - 中国の家禽ワクチン市場規模（2018年-2029年） - 日本の家禽ワクチン市場規模（2018年-2029年） - 韓国の家禽ワクチン市場規模（2018年-2029年） - インドの家禽ワクチン市場規模（2018年-2029年） - オーストラリアの家禽ワクチン市場規模（2018年-2029年） - 中南米の家禽ワクチン市場規模（2018年-2029年） - 中東・アフリカの家禽ワクチン市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Merck、Boehringer Ingelheim、Ceva、Zoetis、Vaxxinova®、Elanco、QYH Biotech Co., Ltd、Pulike、Phibro Animal Health Corporation、JinYu Biotechnology、Harbin Pharmaceutical Group、MEVAC、Venky's、Japfa Comfeed Indonesia、Nisseiken、Hile、Hester Biosciences ・アナリストの観点/結論 ・調査方法とデータソース |
Vaccination plays an important part in the health management of the poultry flock. There are numerous diseases that are prevented by vaccinating the birds against them. A vaccine helps to prevent a particular disease by triggering or boosting the bird’s immune system to produce antibodies that in turn fight the invading causal organisms.
Highlights
The global Poultry Vaccines market was valued at US$ 4463.6 million in 2022 and is anticipated to reach US$ 5812.7 million by 2029, witnessing a CAGR of 4.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key poultry vaccines players hold a share about Merck, Boehringer Ingelheim and Ceva etc. The top 3 companies hold a share about 35%. Asia-Pacific is the largest market with a share about 51%, followed by North America and Europe.
In terms of product, killed vaccine is the largest segment with a share about 72%. And in terms of applications, the largest application is NDV with a share about 25%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Poultry Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poultry Vaccines.
The Poultry Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Poultry Vaccines market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poultry Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova®
Elanco
QYH Biotech Co., Ltd
Pulike
Phibro Animal Health Corporation
JinYu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Venky’s
Japfa Comfeed Indonesia
Nisseiken
Hile
Hester Biosciences
Segment by Type
Live
Attenuated
Killed
Segment by Application
NDV
Marek ‘ s Disease
IBD
Infectious Bronchitis
Influenza
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Poultry Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Poultry Vaccines Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Live
1.2.3 Attenuated
1.2.4 Killed
1.3 Market by Application
1.3.1 Global Poultry Vaccines Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 NDV
1.3.3 Marek ‘ s Disease
1.3.4 IBD
1.3.5 Infectious Bronchitis
1.3.6 Influenza
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Poultry Vaccines Market Perspective (2018-2029)
2.2 Poultry Vaccines Growth Trends by Region
2.2.1 Global Poultry Vaccines Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Poultry Vaccines Historic Market Size by Region (2018-2023)
2.2.3 Poultry Vaccines Forecasted Market Size by Region (2024-2029)
2.3 Poultry Vaccines Market Dynamics
2.3.1 Poultry Vaccines Industry Trends
2.3.2 Poultry Vaccines Market Drivers
2.3.3 Poultry Vaccines Market Challenges
2.3.4 Poultry Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Poultry Vaccines Players by Revenue
3.1.1 Global Top Poultry Vaccines Players by Revenue (2018-2023)
3.1.2 Global Poultry Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global Poultry Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Poultry Vaccines Revenue
3.4 Global Poultry Vaccines Market Concentration Ratio
3.4.1 Global Poultry Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Poultry Vaccines Revenue in 2022
3.5 Poultry Vaccines Key Players Head office and Area Served
3.6 Key Players Poultry Vaccines Product Solution and Service
3.7 Date of Enter into Poultry Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Poultry Vaccines Breakdown Data by Type
4.1 Global Poultry Vaccines Historic Market Size by Type (2018-2023)
4.2 Global Poultry Vaccines Forecasted Market Size by Type (2024-2029)
5 Poultry Vaccines Breakdown Data by Application
5.1 Global Poultry Vaccines Historic Market Size by Application (2018-2023)
5.2 Global Poultry Vaccines Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Poultry Vaccines Market Size (2018-2029)
6.2 North America Poultry Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Poultry Vaccines Market Size by Country (2018-2023)
6.4 North America Poultry Vaccines Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Poultry Vaccines Market Size (2018-2029)
7.2 Europe Poultry Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Poultry Vaccines Market Size by Country (2018-2023)
7.4 Europe Poultry Vaccines Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Poultry Vaccines Market Size (2018-2029)
8.2 Asia-Pacific Poultry Vaccines Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Poultry Vaccines Market Size by Region (2018-2023)
8.4 Asia-Pacific Poultry Vaccines Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Poultry Vaccines Market Size (2018-2029)
9.2 Latin America Poultry Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Poultry Vaccines Market Size by Country (2018-2023)
9.4 Latin America Poultry Vaccines Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Poultry Vaccines Market Size (2018-2029)
10.2 Middle East & Africa Poultry Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Poultry Vaccines Market Size by Country (2018-2023)
10.4 Middle East & Africa Poultry Vaccines Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Poultry Vaccines Introduction
11.1.4 Merck Revenue in Poultry Vaccines Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Poultry Vaccines Introduction
11.2.4 Boehringer Ingelheim Revenue in Poultry Vaccines Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Ceva
11.3.1 Ceva Company Detail
11.3.2 Ceva Business Overview
11.3.3 Ceva Poultry Vaccines Introduction
11.3.4 Ceva Revenue in Poultry Vaccines Business (2018-2023)
11.3.5 Ceva Recent Development
11.4 Zoetis
11.4.1 Zoetis Company Detail
11.4.2 Zoetis Business Overview
11.4.3 Zoetis Poultry Vaccines Introduction
11.4.4 Zoetis Revenue in Poultry Vaccines Business (2018-2023)
11.4.5 Zoetis Recent Development
11.5 Vaxxinova®
11.5.1 Vaxxinova® Company Detail
11.5.2 Vaxxinova® Business Overview
11.5.3 Vaxxinova® Poultry Vaccines Introduction
11.5.4 Vaxxinova® Revenue in Poultry Vaccines Business (2018-2023)
11.5.5 Vaxxinova® Recent Development
11.6 Elanco
11.6.1 Elanco Company Detail
11.6.2 Elanco Business Overview
11.6.3 Elanco Poultry Vaccines Introduction
11.6.4 Elanco Revenue in Poultry Vaccines Business (2018-2023)
11.6.5 Elanco Recent Development
11.7 QYH Biotech Co., Ltd
11.7.1 QYH Biotech Co., Ltd Company Detail
11.7.2 QYH Biotech Co., Ltd Business Overview
11.7.3 QYH Biotech Co., Ltd Poultry Vaccines Introduction
11.7.4 QYH Biotech Co., Ltd Revenue in Poultry Vaccines Business (2018-2023)
11.7.5 QYH Biotech Co., Ltd Recent Development
11.8 Pulike
11.8.1 Pulike Company Detail
11.8.2 Pulike Business Overview
11.8.3 Pulike Poultry Vaccines Introduction
11.8.4 Pulike Revenue in Poultry Vaccines Business (2018-2023)
11.8.5 Pulike Recent Development
11.9 Phibro Animal Health Corporation
11.9.1 Phibro Animal Health Corporation Company Detail
11.9.2 Phibro Animal Health Corporation Business Overview
11.9.3 Phibro Animal Health Corporation Poultry Vaccines Introduction
11.9.4 Phibro Animal Health Corporation Revenue in Poultry Vaccines Business (2018-2023)
11.9.5 Phibro Animal Health Corporation Recent Development
11.10 JinYu Biotechnology
11.10.1 JinYu Biotechnology Company Detail
11.10.2 JinYu Biotechnology Business Overview
11.10.3 JinYu Biotechnology Poultry Vaccines Introduction
11.10.4 JinYu Biotechnology Revenue in Poultry Vaccines Business (2018-2023)
11.10.5 JinYu Biotechnology Recent Development
11.11 Harbin Pharmaceutical Group
11.11.1 Harbin Pharmaceutical Group Company Detail
11.11.2 Harbin Pharmaceutical Group Business Overview
11.11.3 Harbin Pharmaceutical Group Poultry Vaccines Introduction
11.11.4 Harbin Pharmaceutical Group Revenue in Poultry Vaccines Business (2018-2023)
11.11.5 Harbin Pharmaceutical Group Recent Development
11.12 MEVAC
11.12.1 MEVAC Company Detail
11.12.2 MEVAC Business Overview
11.12.3 MEVAC Poultry Vaccines Introduction
11.12.4 MEVAC Revenue in Poultry Vaccines Business (2018-2023)
11.12.5 MEVAC Recent Development
11.13 Venky’s
11.13.1 Venky’s Company Detail
11.13.2 Venky’s Business Overview
11.13.3 Venky’s Poultry Vaccines Introduction
11.13.4 Venky’s Revenue in Poultry Vaccines Business (2018-2023)
11.13.5 Venky’s Recent Development
11.14 Japfa Comfeed Indonesia
11.14.1 Japfa Comfeed Indonesia Company Detail
11.14.2 Japfa Comfeed Indonesia Business Overview
11.14.3 Japfa Comfeed Indonesia Poultry Vaccines Introduction
11.14.4 Japfa Comfeed Indonesia Revenue in Poultry Vaccines Business (2018-2023)
11.14.5 Japfa Comfeed Indonesia Recent Development
11.15 Nisseiken
11.15.1 Nisseiken Company Detail
11.15.2 Nisseiken Business Overview
11.15.3 Nisseiken Poultry Vaccines Introduction
11.15.4 Nisseiken Revenue in Poultry Vaccines Business (2018-2023)
11.15.5 Nisseiken Recent Development
11.16 Hile
11.16.1 Hile Company Detail
11.16.2 Hile Business Overview
11.16.3 Hile Poultry Vaccines Introduction
11.16.4 Hile Revenue in Poultry Vaccines Business (2018-2023)
11.16.5 Hile Recent Development
11.17 Hester Biosciences
11.17.1 Hester Biosciences Company Detail
11.17.2 Hester Biosciences Business Overview
11.17.3 Hester Biosciences Poultry Vaccines Introduction
11.17.4 Hester Biosciences Revenue in Poultry Vaccines Business (2018-2023)
11.17.5 Hester Biosciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details